MilliporeSigma
Search Within

HPA000923

Applied Filters:
Keyword:'HPA000923'
Showing 1-8 of 8 results for "HPA000923" within Papers
Ayumi Matsumoto et al.
BMC nephrology, 22(1), 253-253 (2021-07-08)
Phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type-1 domain-containing 7A (THSD7A) are the two major pathogenic antigens for membranous nephropathy (MN). It has been reported that THSD7A-associated MN has a higher prevalence of comorbid malignancy than PLA2R1-associated MN. Here we
Priyadarsani Subramanian et al.
Kidney international reports, 5(9), 1551-1557 (2020-09-22)
The majority of primary membranous nephropathy (MN) cases are no longer considered idiopathic with the discovery of the podocytic autoantigens: phospholipase A2 receptor (PLA2R) and thrombospondin type 1 domain-containing 7A (THSD7A). Limited data on PLA2R-related MN in Indians exist in
M Fresquet et al.
Journal of autoimmunity, 106, 102308-102308 (2019-08-10)
Patients with membranous nephropathy have autoantibodies against PLA2R (up to 80%), or THSD7A (up to 2%). We previously described the immunodominant epitope within PLA2R but epitopes in THSD7A are still unknown. To find anti-THSD7A sera for this study, we screened
Phillip R Stahl et al.
Genes, chromosomes & cancer, 56(4), 314-327 (2016-12-31)
We recently described a case of a Thrombospondin Type-1 Domain containing 7A (THSD7A) associated membranous nephropathy in a female patient who was synchronously suffering from a THSD7A-positive malignancy. We here investigated the role of THSD7A as a new potential tumor
Li Xian et al.
BMC nephrology, 20(1), 332-332 (2019-08-25)
Thrombospondin type 1 domain containing 7A (THSD7A) was recently identified target autoantigen in membranous nephropathy (MN). However, patients with positive THSD7A expression were prone to have malignancies. THSD7A was found to be expressed in a variety of malignant tumors. In
Madoka Morimoto et al.
CEN case reports, 10(1), 6-11 (2020-07-10)
Bevacizumab is a monoclonal antibody against vascular endothelial growth factor (VEGF) that is used to treat patients with various cancers. However, it is known to be associated with adverse events, such as hypertension and proteinuria. The histology of bevacizumab-induced nephropathy
Fidelis Andrea Flockerzi et al.
Diagnostics (Basel, Switzerland), 13(2) (2023-01-22)
Prostate cancer is one of the most common malignancies, and there are a wide range of treatment options after diagnosis. Most prostate cancers behave in an indolent manner. However, a given sub-group has been shown to exhibit aggressive behavior; therefore
Fidelis Andrea Flockerzi et al.
International journal of molecular sciences, 24(13) (2023-07-14)
Lung cancer is the leading cause of cancer-related deaths in the western world, with squamous cell carcinoma being one of the most common histological subtypes. Prognostic and predictive markers are still largely missing for squamous cell carcinoma of the lung
Page 1 of 1